why are there so many glp 1 drugs Can one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonists GLP-1 Agonists Weight Loss Drugs

Although minimal processing was observed in fibroblasts, immunoreactive GLP-1 and GLP-2 was detected by chromatography and radioimmunoassays in medium and extracts from transfected pituitary and islet cells (15)

Liraglutide and semaglutide are long-acting human GLP-1 analogues with high receptor affinity and sustained receptor occupancy, whereas dulaglutide is a larger fusion molecule conjugated to an IgG4 Fc fragment, resulting in distinct pharmacokinetics and tissue distribution

There was no significant reported difference in the eGFR decline from baseline to the end of treatment or in the rate of renal death ( 2 ) was safe and effective (Mosenzon et al., 2019a)

Cost falls in the moderate range

No benefit in terms of the risk of HF hospitalization was observed with oral semaglutide, as well as with efpeglenatide (43, 44)

Blackwell Publishing